Bioavailability and recent advances in the bioactivity of flavonoid and stilbene compounds

Current Organic Chemistry

Volumn 14, Issue 16, 2010, Pages 1727-1751

  Lim, Chin Giaw ^a   Koffas, Mattheos A G ^a  

^a The State University of New York ^*  (United States)

Author keywords

Absorption; Bioactivity; Bioavailability; Distribution; Excretion; Flavonoids; Metabolism; Polyphenols; Resveratrol

Indexed keywords

FLAVONOIDS; HISTOLOGY; METABOLISM; PHYSIOLOGY; TISSUE;

ABSORPTION DISTRIBUTION METABOLISM AND EXCRETIONS; BIOAVAILABILITY; BIOAVAILABILTY; DISTRIBUTION; EXCRETION; FLAVONOID; FLAVONOIDS COMPOUNDS; ISOFLAVONES; POLYPHENOLS; STILBENE COMPOUNDS;

BIOACTIVITY;

EID: 78649913081     PISSN: 13852728     EISSN: None     Source Type: Journal    
DOI: 10.2174/138527210792927654     Document Type: Article

References (299)

1. Lepiniec, L.; Debeaujon, I.; Routaboul, J.-M.; Baudry, A.; Pourcel, L.; Nesi, N.; Caboche, M. Genetics and biochemistry of seed flavonoids. Annu. Rev. Plant Biol., 2006, 57, 405-430.
2. Gould, K. S.; Lister, C. Flavonoid functions in plants. Flavonoids, 2006, 397-441.
3. Jones, K. M.; Kobayashi, H.; Davies, B. W.; Taga, M. E.; Walker, G. C. How rhizobial symbionts invade plants: the Sinorhizobium-Medicago model. Nat. Rev. Microb., 2007, 5(8), 619-633.
4. Middleton, E., Jr.; Kandaswami, C.; Theoharides, T. C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev., 2000, 52(4), 673-751.
5. Chemler, J. A.; Koffas, M. A. G. Metabolic engineering for plant natural product biosynthesis in microbes. Curr. Opin. Biotechnol., 2008, 19(6), 597-605.
6. Watts, K.; Lee, P.; Schmidt-Dannert, C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol., 2006, 6(1), 22.
7. King, R. E.; Bomser, J. A.; Min, D. B. Bioactivity of Resveratrol. Compr. Rev. Food Sci. Food Safety, 2006, 5(3), 65-70.
8. Justesen, U.; Knuthsen, P.; Leth, T. Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by highperformance liquid chromatography with photo-diode array and mass spectrometric detection. J. Chromatogr. A, 1998, 799(1-2), 101-110.
9. Peterson, J. J.; Beecher, G. R.; Bhagwat, S. A.; Dwyer, J. T.; Gebhardt, S. E.; Haytowitz, D. B.; Holden, J. M. Flavanones in grapefruit, lemons, and limes: A compilation and review of the data from the analytical literature. J. Food Composit. Anal., 2006, 19(Suppl. 1), S74-S80.
10. Kyle, J. A. M.; Duthie, G. G. Flavonoids in foods. Flavonoids., 2006, 219-262.
11. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
12. Fukutake, M.; Takahashi, M.; Ishida, K.; Kawamura, H.; Sugimura, T.; Wakabayashi, K. Quantification of genistein and genistin in soybeans and soybean products. Food Chem. Toxicol., 1996, 34(5), 457-461.
13. Hollman, P. C. H.; Arts, I. C. W. Flavonols, flavones and flavanols-nature, occurrence and dietary burden. J. Sci. Food Agric., 2000, 80(7), 1081-1093.
14. Baur, J. A.; Pearson, K. J.; Price, N. L.; Jamieson, H. A.; Lerin, C.; Kalra, A.; Prabhu, V. V.; Allard, J. S.; Lopez-Lluch, G.; Lewis, K.; Pistell, P. J.; Poosala, S.; Becker, K. G.; Boss, O.; Gwinn, D.; Mingyi, W.; Ramaswamy, S.; Fishbein, K. W.; Spencer, R. G.; Lakatta, E. G. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444(7117), 337-342.
15. Opie, L. H.; Lecour, S. The red wine hypothesis: from concepts to protective signalling molecules. Eur. Heart. J., 2007, 28(14), 1683-1693.
16. Austin, M. B.; Bowman, M. E.; Ferrer, J. L.; Schroder, J.; Noel, J. P. An aldol switch discovered in stilbene synthases mediates cyclization specificity of type III polyketide synthases. Chem. Biol., 2004, 11(9), 1179-1194.
17. Morita, H.; Noguchi, H.; Schroder, J.; Abe, I. Novel polyketides synthesized with a higher plant stilbene synthase. Eur. J. Biochem., 2001, 268(13), 3759-3766.
18. Chemier, J. A.; Fowler, Z. L.; Koffas, M. A.; Leonard, E. Trends in microbial synthesis of natural products and biofuels. Adv. Enzymol. Relat. Areas. Mol. Biol., 2009, 76, 151-217.
19. Akashi, T.; Aoki, T.; Ayabe, S. Molecular and biochemical characterization of 2-hydroxyisoflavanone dehydratase. Involvement of carboxylesterase-like proteins in leguminous isoflavone biosynthesis. Plant Physiol., 2005, 137(3), 882-891.
20. Biddle, M. M.; Lin, M.; Scheidt, K. A. Catalytic Enantioselective Synthesis of Flavanones and Chromanones. J. Am. Chem. Soc., 2007, 129(13), 3830-3831.
21. Su, W. W. Bioreactor engineering for recombinant protein production using plant cell suspension culture. Focus Biotechnol., 2008, 6, 135-159.
22. Wellmann, E. Ultraviolet dose-dependent induction of enzymes related to flavonoid biosynthesis in cell suspension cultures of parsley. FEBS Lett., 1975, 51(1), 105-107.
23. Meyer, J. E.; Pepin, M. F.; Smith, M. A. L. Anthocyanin production from Vaccinium pahalae: limitations of the physical microenvironment. J. Biotechnol., 2002, 93(1), 45-57.
24. Zhong, J. J.; Seki, T.; Kinoshita, S.; Yoshida, T. Effect of light irradiation on anthocyanin production by suspended culture of Perilla frutescens. Biotechnol. Bioeng., 1991, 38(6), 653-658.
25. Leonard, E.; Koffas, M. A. G. Engineering of artificial plant cytochrome P450 enzymes for synthesis of isoflavones by Escherichia coli. Appl. Environ. Microbiol., 2007, 73(22), 7246-7251.
26. Hannemann, F.; Bichet, A.; Ewen, K. M.; Bernhardt, R. Cytochrome P 450 systems-biological variations of electron transport chains. Biochim. Biophysi. Acta, 2007, 1770(3), 330-344.
27. Tomas-Barberan, F. A.; Garcia-Conesca, M. T.; Larrosa, M.; Cerda, B.; Gonzalez-Barrio, R.; Bermudez-Soto, M. J.; Gonzalez-Sarrias, A.; Espin, J. C. Bioavailability, metabolism, and bioactivity of food ellagic acid and related polyphenols. Recent Adv. Polyphenol Res., 2008, 1, 263-277.
28. Zhang, L.; Zuo, Z.; Lin, G. Intestinal and Hepatic Glucuronidation of Flavonoids. Mol. Pharmaceut., 2007, 4(6), 833-845.
29. Walle, T. Absorption and metabolism of flavonoids. Free Radic. Biol. Med., 2004, 36(7), 829-837.
30. Prasain, J. K.; Barnes, S. Metabolism and Bioavailability of Flavonoids in Chemoprevention: Current Analytical Strategies and Future Prospectus. Mol. Pharmaceut., 2007, 4(6), 846-864.
31. Walle, T.; Vincent, T. S.; Walle, U. K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol., 2003, 65(10), 1603-1610.
32. Brett, G. M.; Hollands, W.; Needs, P. W.; Teucher, B.; R. Dainty, J.; Davis, B. D.; Brodbelt, J. S.; Kroon, P. A. Absorption, metabolism and excretion of flavanones from single portions of orange fruit and juice and effects of anthropometric variables and contraceptive pill use on flavanone excretion. Br. J. Nutr., 2009, 101(05), 664-675.
33. Manach, C.; Morand, C.; Gil-Izquierdo, A.; Bouteloup-Demange, C.; Remesy, C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur. J. Clin. Nutr., 2003, 57(2), 235-242.
34. Mata-Bilbao Mde, L.; Andres-Lacueva, C.; Roura, E.; Jauregui, O.; Escribano, E.; Torre, C.; Lamuela-Raventos, R. M. Absorption and pharmacokinetics of grapefruit flavanones in beagles. Br. J. Nutr., 2007, 98(1), 86-92.
35. Bugianesi, R.; Catasta, G.; Spigno, P.; D'Uva, A.; Maiani, G. Naringenin from Cooked Tomato Paste Is Bioavailable in Men. J. Nutr., 2002, 132(11), 3349-3352.
36. Stalmach, A.; Mullen, W.; Pecorari, M.; Serafini, M.; Crozier, A. Bioavailability of C-linked dihydrochalcone and flavanone glucosides in humans following ingestion of unfermented and fermented rooibos teas. J. Agric. Food Chem., 2009, 57(15), 7104-7111.
37. Hollman, P. C. H.; Bijsman, M. N. C. P.; van Gameren, Y.; Cnossen, E. P. J.; de Vries, J. H. M.; Katan, M. B. The sugar moiety is a major determinant of the absorption of dietary flavonoid glycosides in man. Free Radic. Res., 1999, 31(6), 569-573.
38. Nielsen, I. L. F.; Chee, W. S. S.; Poulsen, L.; Offord-Cavin, E.; Rasmussen, S. E.; Frederiksen, H.; Enslen, M.; Barron, D.; Horcajada, M.-N.; Williamson, G. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J. Nutr., 2006, 136(2), 404-408.
39. Kanaze, F. I.; Bounartzi, M. I.; Georgarakis, M.; Niopas, I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur. J. Clin. Nutr., 2006, 61(4), 472-477.
40. Clifford, M.; Brown, J. E. Dietary flavonoids and health-broadening the perspective. Flavonoids, 2006, 319-370.
41. Felgines, C.; Texier, O.; Morand, C.; Manach, C.; Scalbert, A.; Regerat, F.; Remesy, C. Bioavailability of the flavanone naringenin and its glycosides in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 2000, 279(6), G1148-G1154.
42. Heo, H. J.; Kim, D.-O.; Shin, S. C.; Kim, M. J.; Kim, B. G.; Shin, D.-H. Effect of Antioxidant Flavanone, Naringenin, from Citrus junos on Neuroprotection. J. Agric. Food Chem., 2004, 52(6), 1520-1525.
43. Pari, L.; Gnanasoundari, M. Influence of Naringenin on Oxytetracycline Mediated Oxidative Damage in Rat Liver. Basic Clin. Pharmacol. Toxicol., 2006, 98(5), 456-461.
44. Andrade, J. E.; Burgess, J. R. Effect of the Citrus Flavanone Naringenin on Oxidative Stress in Rats. J. Agric. Food Chem., 2007, 55(6), 2142-2148.
45. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara, A.; Sumida, T.; Ogawa, H. Chemoprevention of azoxymethaneinduced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis, 1997, 18(5), 957-965.
46. Tanaka, T.; Kohno, H.; Murakami, M.; Shimada, R.; Kagami, S.; Sumida, T.; Azuma, Y.; Ogawa, H. Suppression of azoxymethane-induced colon carcinogenesis in male F344 rats by mandarin juices rich in betacryptoxanthin and hesperidin. Int. J. Cancer, 2000, 88(1), 146-150.
47. Kohno, H.; Taima, M.; Sumida, T.; Azuma, Y.; Ogawa, H.; Tanaka, T. Inhibitory effect of mandarin juice rich in [beta]-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice. Cancer Lett., 2001, 174(2), 141-150.
48. Aranganathan, S.; Panneer Selvam, J.; Sangeetha, N.; Nalini, N. Modulatory efficacy of hesperetin(citrus flavanone) on xenobiotic-metabolizing enzymes during 1,2-dimethylhydrazine-induced colon carcinogenesis. Chemico-Biol. Interact., 2009, 180(2), 254-261.
49. Ekambaram, G.; Rajendran, P.; Magesh, V.; Sakthisekaran, D. Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidineinduced gastric carcinogenesis in rats. Nutr. Res., 2008, 28(2), 106-112.
50. Falcao, M. J. C.; Pouliquem, Y. B. M.; Lima, M. A. S.; Gramosa, N. V.; Costa-Lotufo, L. V.; Militao, G. C. G.; Pessoa, C.; Odorico de Moraes, M.; Silveira, E. R. Cytotoxic Flavonoids from Platymiscium floribundum. J. Nat.Prod., 2005, 68(3), 423-426.
51. Zhang, S.-P.; Zhou, Y.-J.; Liu, Y.; Cai, Y.-Q. Effect of liquiritigenin, a flavanone existed from Radix glycyrrhizae on pro-apoptotic in SMMC-7721 cells. Food Chem. Toxicol., 2009, 47(4), 693-701.
52. Vafeiadou, K.; Vauzour, D.; Lee, H. Y.; Rodriguez-Mateos, A.; Williams, R. J.; Spencer, J. P. E. The citrus flavanone naringenin inhibits inflammatory signalling in glial cells and protects against neuroinflammatory injury. Arch. Biochem. Biophys., 2009, 484(1), 100-109.
53. Bodet, C.; La, V. D.; Epifano, F.; Grenier, D. Naringenin has anti-inflammatory properties in macrophage and ex vivo human whole-blood models. J. Periodontal Res., 2008, 43(4), 400-407.
54. Inês Amaro, M.; Rocha, J.; Vila-Real, H.; Eduardo-Figueira, M.; Mota-Filipe, H.; Sepodes, B.; Ribeiro, M. H. Anti-inflammatory activity of naringin and the biosynthesised naringenin by naringinase immobilized in microstructured materials in a model of DSS-induced colitis in mice. Food Res. Int., 2009, 42(8), 1010-1017.
55. Hwang, T.-L.; Li, G.-L.; Lan, Y.-H.; Chia, Y.-C.; Hsieh, P.-W.; Wu, Y.-H.; Wu, Y.-C. Potent inhibition of superoxide anion production in activated human neutrophils by isopedicin, a bioactive component of the Chinese medicinal herb Fissistigma oldhamii. Free Radic. Biol. Med., 2009, 46(4), 520-528.
56. Jeon, S.-M.; Kim, H. K.; Kim, H.-J.; Do, G.-M.; Jeong, T.-S.; Park, Y. B.; Choi, M.-S. Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats. Transl. Res., 2007, 149(1), 15-21.
57. Rajadurai, M.; Stanely Mainzen Prince, P. Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. Toxicology, 2007, 232(3), 216-225.
58. Szkudelska, K.; Nogowski, L.; Nowicka, E.; Szkudelski, T. In vivo metabolic effects of naringenin in the ethanol consuming rat and the effect of naringenin on adipocytes in vitro. J. Anim. Physiol. Anim. Nutr., 2007, 91(3-4), 91-99.
59. Franke, A. A.; Cooney, R. V.; Henning, S. M.; Custer, L. J. Bioavailability and Antioxidant Effects of Orange Juice Components in Humans. J. Agric. Food Chem., 2005, 53(13), 5170-5178.
60. Ghanim, H.; Mohanty, P.; Pathak, R.; Chaudhuri, A.; Sia, C. L.; Dandona, P. Orange Juice or Fructose Intake Does Not Induce Oxidative and Inflammatory Response. Diabetes Care, 2007, 30(6), 1406-1411.
61. Ortiz-Andrade, R. R.; Sanchez-Salgado, J. C.; Navarrete-Vazquez, G.; Webster, S. P.; Binnie, M.; Garcia-Jimenez, S.; Leon-Rivera, I.; Cigarroa-Vazquez, P.; Villalobos-Molina, R.; Estrada-Soto, S. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes. Metab., 2008, 10(11), 1097-1104.
62. Izumi, T.; Piskula, M. K.; Osawa, S.; Obata, A.; Tobe, K.; Saito, M.; Kataoka, S.; Kubota, Y.; Kikuchi, M. Soy Isoflavone Aglycones Are Absorbed Faster and in Higher Amounts than Their Glucosides in Humans. J. Nutr., 2000, 130(7), 1695-1699.
63. Kano, M.; Takayanagi, T.; Harada, K.; Sawada, S.; Ishikawa, F. Bioavailability of Isoflavones after Ingestion of Soy Beverages in Healthy Adults. J. Nutr., 2006, 136(9), 2291-2296.
64. Cassidy, A.; Brown, J. E.; Hawdon, A.; Faughnan, M. S.; King, L. J.; Millward, J.; Zimmer-Nechemias, L.; Wolfe, B.; Setchell, K. D. R. Factors Affecting the Bioavailability of Soy Isoflavones in Humans after Ingestion of Physiologically Relevant Levels from Different Soy Foods. J. Nutr., 2006, 136(1), 45-51.
65. Setchell, K. D. R.; Brown, N. M.; Desai, P.; Zimmer-Nechemias, L.; Wolfe, B. E.; Brashear, W. T.; Kirschner, A. S.; Cassidy, A.; Heubi, J. E. Bioavailability of Pure Isoflavones in Healthy Humans and Analysis of Commercial Soy Isoflavone Supplements. J. Nutr., 2001, 131(4), 1362S-1375S.
66. Richelle, M.; Pridmore-Merten, S.; Bodenstab, S.; Enslen, M.; Offord, E. A. Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J. Nutr., 2002, 132(9), 2587-2592.
67. Zubik, L.; Meydani, M. Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am. J. Clin. Nutr., 2003, 77(6), 1459-1465.
68. Setchell, K. D.; Brown, N. M.; Zimmer-Nechemias, L.; Brashear, W. T.; Wolfe, B. E.; Kirschner, A. S.; Heubi, J. E. Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability. Am. J. Clin. Nutr., 2002, 76(2), 447-453.
69. Clarke, D. B.; Lloyd, A. S.; Botting, N. P.; Oldfield, M. F.; Needs, P. W.; Wiseman, H. Measurement of intact sulfate and glucuronide phytoestrogen conjugates in human urine using isotope dilution liquid chromatographytandem mass spectrometry with [13C3]isoflavone internal standards. Anal. Biochem., 2002, 309(1), 158-172.
70. Vergne, S.; Sauvant, P.; Lamothe, V.; Chantre, P.; Asselineau, J.; Perez, P.; Durand, M.; Moore, N.; Bennetau-Pelissero, C. Influence of ethnic origin(Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones. Br. J. Nutr., 2009, 102(11), 1642-1653.
71. Espín, J. C.; García-Conesa, M. T.; Tomás-Barberán, F. A. Nutraceuticals: Facts and fiction. Phytochemistry, 2007, 68(22-24), 2986-3008.
72. Squadrito, F.; Altavilla, D.; Crisafulli, A.; Saitta, A.; Cucinotta, D.; Morabito, N.; D'Anna, R.; Corrado, F.; Ruggeri, P.; Frisina, N.; Squadrito, G. Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study. Am. J. Med., 2003, 114(6), 470-476.
73. Siow, R. C. M.; Li, F. Y. L.; Rowlands, D. J.; de Winter, P.; Mann, G. E. Cardiovascular targets for estrogens and phytoestrogens: Transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic. Biol. Med., 2007, 42(7), 909-925.
74. Limer, J. L.; Speirs, V. Phyto-oestrogens and breast cancer chemoprevention. Breast Cancer Res., 2004, 6(3), 119-127.
75. Lamartiniere, C. A. Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr., 2000, 71(6), 1705S-1707S.
76. Mai, Z.; Blackburn, G. L.; Zhou, J.-R. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogendependent human breast carcinoma in mice. Carcinogenesis, 2007, 28(6), 1217-1223.
77. Lakshman, M.; Xu, L.; Ananthanarayanan, V.; Cooper, J.; Takimoto, C. H.; Helenowski, I.; Pelling, J. C.; Bergan, R. C. Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res., 2008, 68(6), 2024-2032.
78. Akhter, M.; Iwasaki, M.; Yamaji, T.; Sasazuki, S.; Tsugane, S. Dietary isoflavone and the risk of colorectal adenoma: a case-control study in Japan. Br. J. Cancer, 2009, 100(11), 1812-1816.
79. Mezei, O.; Banz, W. J.; Steger, R. W.; Peluso, M. R.; Winters, T. A.; Shay, N. Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells. J. Nutr., 2003, 133(5), 1238-1243.
80. Kim, D. W.; Yoo, K.-Y.; Lee, Y.-B.; Lee, K.-H.; Sohn, H.-S.; Lee, S.-J.; Cho, K.-H.; Shin, Y. K.; Hwang, I. K.; Won, M.-H.; Kim, D.-W. Soy Isoflavones Mitigate Long-Term Femoral and Lumbar Vertebral Bone Loss in Middle-Aged Ovariectomized Mice. J. Med. Food, 2009, 12(3), 536-541.
81. Kawakita, S.; Marotta, F.; Naito, Y.; Gumaste, U.; Jain, S.; Tsuchiya, J.; Minelli, E. Effect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized rats. Clin. Interv. Aging., 2009, 4(1), 91-100.
82. Thorp, A. A.; Sinn, N.; Buckley, J. D.; Coates, A. M.; Howe, P. R. Soya isoflavone supplementation enhances spatial working memory in men. Br. J. Nutr., 2009, 102(9), 1348-1354.
83. Monteiro, S.; de Mattos, C.; Ben, J.; Netto, C.; Wyse, A. Ovariectomy impairs spatial memory: prevention and reversal by a soy isoflavone diet. Metab. Br. Dis., 2008, 23(3), 243-253.
84. Zhuo, X.-G.; Melby, M. K.; Watanabe, S. Soy Isoflavone Intake Lowers Serum LDL Cholesterol: A Meta-Analysis of 8 Randomized Controlled Trials in Humans. J. Nutr., 2004, 134(9), 2395-2400.
85. Taku, K.; Umegaki, K.; Sato, Y.; Taki, Y.; Endoh, K.; Watanabe, S. Soy isoflavones lower serum total and LDL cholesterol in humans: a metaanalysis of 11 randomized controlled trials. Am. J. Clin. Nutr., 2007, 85(4),1148-1156.
86. Taku, K.; Umegaki, K.; Ishimi, Y.; Watanabe, S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials. Ther. Clin. Risk Manag., 2008, 4(5), 1097-1103.
87. Kreijkamp-Kaspers, S.; Kok, L.; Grobbee, D. E.; de Haan, E. H. F.; Aleman, A.; van der Schouw, Y. T. Dietary Phytoestrogen Intake and Cognitive Function in Older Women. J. Gerontol. A. Biol. Sci. Med. Sci., 2007, 62(5), 556-562.
88. Kreijkamp-Kaspers, S.; Kok, L.; Bots, M. L.; Grobbee, D. E.; Lampe, J. W.; van der Schouw, Y. T. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am. J. Clin. Nutr., 2005, 81(1), 189-195.
89. Cassidy, A.; Albertazzi, P.; Nielsen, I. L.; Hall, W.; Williamson, G.; Tetens, I.; Atkins, S.; Cross, H.; Manios, Y.; Wolk, A.; Steiner, C.; Branca, F. Critical review of health effects of soyabean phyto-oestrogens in postmenopausal women. Proc. Nutr. Soc., 2006, 65(01), 76-92.
90. Shimoi, K.; Okada, H.; Furugori, M.; Goda, T.; Takase, S.; Suzuki, M.; Hara, Y.; Yamamoto, H.; Kinae, N. Intestinal absorption of luteolin and luteolin 7-O-[beta]-glucoside in rats and humans. FEBS Lett., 1998, 438(3), 220-224.
91. Wittemer, S. M.; Ploch, M.; Windeck, T.; Müller, S. C.; Drewelow, B.; Derendorf, H.; Veit, M. Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine, 2005, 12(1-2), 28-38.
92. Meyer, H.; Bolarinwa, A.; Wolfram, G.; Linseisen, J. Bioavailability of apigenin from apiin-rich parsley in humans. Ann. Nutr. Metab., 2006, 50(3), 167-172.
93. Walle, T.; Otake, Y.; Brubaker, J. A.; Walle, U. K.; Halushka, P. V. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br. J. Clin. Pharmacol., 2001, 51(2), 143-146.
94. Galijatovic, A.; Otake, Y.; Walle, U. K.; Walle, T. Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells. Xenobiotica,1999, 29(12), 1241-1256.
95. Walle, U. K.; Galijatovic, A.; Walle, T. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2. Biochem. Pharmacol., 1999, 58(3), 431-438.
96. Walle, T.; Ta, N.; Kawamori, T.; Wen, X.; Tsuji, P. A.; Walle, U. K. Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem. Pharmacol., 2007, 73(9), 1288-1296.
97. Walle, T. Methylation of Dietary Flavones Greatly Improves Their Hepatic Metabolic Stability and Intestinal Absorption. Mol. Pharmaceut., 2007, 4(6), 826-832.
98. Wen, X.; Walle, T. Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability. Drug Metab. Dispos., 2006, 34(10), 1786-1792.
99. Tsuji, P. A.; Winn, R. N.; Walle, T. Accumulation and metabolism of the anticancer flavonoid 5,7-dimethoxyflavone compared to its unmethylated analog chrysin in the Atlantic killifish. Chem. Biol. Interact., 2006, 164(1-2), 85-92.
100. Michels, G.; Wätjen, W.; Niering, P.; Steffan, B.; Thi, Q. H. T.; Chovolou, Y.; Kampkötter, A.; Bast, A.; Proksch, P.; Kahl, R. Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology, 2005, 206(3), 337-348.
101. Jeyabal, P. V.; Syed, M. B.; Venkataraman, M.; Sambandham, J. K.; Sakthisekaran, D. Apigenin inhibits oxidative stress-induced macromolecular damage in N-nitrosodiethylamine(NDEA)-induced hepatocellular carcinogenesis in Wistar albino rats. Mol. Carcinog, 2005, 44(1), 11-20.
102. Czy, J. zdot; Zbigniew Madeja; Uwe Irmer; Wlodzimierz Korohoda; Dieter F. Hülser, Flavonoid apigenin inhibits motility and invasiveness of carcinoma cells in vitro. Int. J. Cancer, 2005, 114(1), 12-18.
103. Lee, L. T.; Huang, Y. T.; Hwang, J. J.; Lee, P. P.; Ke, F. C.; Nair, M. P.; Kanadaswam, C.; Lee, M. T. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res., 2002, 22(3), 1615-1627.
104. Shukla, S.; Gupta, S. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study. Molecular Carcinogenesis, 2009, 48(3), 243-252.
105. Kaur, P.; Shukla, S.; Gupta, S. Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study. Carcinogenesis, 2008, 29(11), 2210-2217.
106. Vargo, M. A.; Voss, O. H.; Poustka, F.; Cardounel, A. J.; Grotewold, E.; Doseff, A. I. Apigenin-induced-apoptosis is mediated by the activation of PKCdelta and caspases in leukemia cells. Biochem. Pharmacol., 2006, 72(6), 681-692.
107. Choi, E. J.; Kim, G. H. Apigenin Induces Apoptosis through a Mitochondria/Caspase-Pathway in Human Breast Cancer MDA-MB-453 Cells. J. Clin. Biochem. Nutr., 2009, 44(3), 260-265.
108. Jin, B.-H.; Qian, L.-B.; Chen, S.; Li, J.; Wang, H.-P.; Bruce, I. C.; Lin, J.; Xia, Q. Apigenin protects endothelium-dependent relaxation of rat aorta against oxidative stress. Eur. J. Pharmacol., 2009, 616(1-3), 200-205.
109. Ma, X.; Li, Y. F.; Gao, Q.; Ye, Z. G.; Lu, X. J.; Wang, H. P.; Jiang, H. D.; Bruce, I. C.; Xia, Q. Inhibition of superoxide anion-mediated impairment of endothelium by treatment with luteolin and apigenin in rat mesenteric artery. Life Sci., 2008, 83(3-4), 110-117.
110. Yamagata, K.; Miyashita, A.; Matsufuji, H.; Chino, M. Dietary flavonoid apigenin inhibits high glucose and tumor necrosis factor alpha-induced adhesion molecule expression in human endothelial cells. J. Nutr. Biochem., 21(2), 116-124.
111. Shin, E. K.; Kwon, H.-S.; Kim, Y. H.; Shin, H.-K.; Kim, J.-K. Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochem. Biophys. Res. Commun., 2009, 381(4), 502-507.
112. Geraets, L.; Haegens, A.; Brauers, K.; Haydock, J. A.; Vernooy, J. H. J.; Wouters, E. F. M.; Bast, A.; Hageman, G. J. Inhibition of LPS-induced pulmonary inflammation by specific flavonoids. Biochem. Biophys. Res. Commun., 2009, 382(3), 598-603.
113. Duraj, J.; Zazrivcova, K.; Bodo, J.; Sulikova, M.; Sedlak, J. Flavonoid quercetin, but not apigenin or luteolin, induced apoptosis in human myeloid leukemia cells and their resistant variants. Neoplasma, 2005, 52(4), 273-279.
114. Janssen, K.; Mensink, R.; Cox, F.; Harryvan, J.; Hovenier, R.; Hollman, P.; Katan, M. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr., 1998, 67(2), 255-262.
115. Pietta, P.-G. Flavonoids as Antioxidants. J. Nat. Products, 2000, 63(7), 1035-1042.
116. Michels, G.; Mohamed, G. A.; Weber, N.; Chovolou, Y.; Kampkotter, A.; Watjen, W.; Proksch, P. Effects of methylated derivatives of Luteolin isolated from Cyperus alopecuroides in rat H4IIE hepatoma cells*. Basic Clin. Pharmacol. Toxicol., 2006, 98(2), 168-172.
117. Williams, R. J.; Spencer, J. P. E.; Rice-Evans, C. Flavonoids: antioxidants or signalling molecules? Free Radic. Biol. Med., 2004, 36(7), 838-849.
118. Akao, Y.; itoh, T.; Ohguchi, K.; Iinuma, M.; Nozawa, Y. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg. Med. Chem., 2008, 16(6), 2803-2810.
119. Wen, X.; Walle, T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis, 2005, 26(10), 1774-1781.
120. Wen, X.; Walle, U. K.; Walle, T. 5,7-Dimethoxyflavone downregulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis, 2005, 26(4), 803-809.
121. Cai, H.; Sale, S.; Schmid, R.; Britton, R. G.; Brown, K.; Steward, W. P.; Gescher, A. J. Flavones as Colorectal Cancer Chemopreventive Agents--Phenol-O-Methylation Enhances Efficacy. Cancer Prev. Res., 2009, 2(8), 743-750.
122. Hollman, P.; de Vries, J.; van Leeuwen, S.; Mengelers, M.; Katan, M. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am. J. Clin. Nutr., 1995, 62(6), 1276-1282.
123. Graefe, E.; Wittig, J.; Mueller, S.; Riethling, A.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol., 2001, 41(5), 492-499.
124. Wiczkowski, W.; Romaszko, J.; Bucinski, A.; Szawara-Nowak, D.; Honke, J.; Zielinski, H.; Piskula, M. K. Quercetin from Shallots(Allium cepa L. var. aggregatum) Is More Bioavailable Than Its Glucosides. J. Nutr., 2008, 138(5), 885-888.
125. Day, A. J.; Mellon, F.; Barron, D.; Sarrazin, G.; Morgan, M. R.; Williamson, G. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res., 2001, 35(6), 941-952.
126. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230S-242S.
127. Kawai, Y.; Saito, S.; Nishikawa, T.; Ishisaka, A.; Murota, K.; Terao, J. Different Profiles of Quercetin Metabolites in Rat Plasma: Comparison of Two Administration Methods. Biosci. Biotechnol. Biochem., 2009, 73(3), 517-523.
128. Bieger, J.; Cermak, R.; Blank, R.; de Boer, V. C. J.; Hollman, P. C. H.; Kamphues, J.; Wolffram, S. Tissue distribution of quercetin in pigs after long-term dietary supplementation. J. Nutr., 2008, 138(8), 1417-1420.
129. Tamura, M.; Nakagawa, H.; Tsushida, T.; Hirayama, K.; Itoh, K. Effect of Pectin Enhancement on Plasma Quercetin and Fecal Flora in Rutin-Supplemented Mice. J. Food Sci., 2007, 72(9), S648-S651.
130. Nishijima, T.; Iwai, K.; Saito, Y.; Takida, Y.; Matsue, H. Chronic Ingestion of Apple Pectin Can Enhance the Absorption of Quercetin. J. Agric. Food Chem., 2009, 57(6), 2583-2587.
131. Muthukumaran, S.; Sudheer, A. R.; Menon, V. P.; Nalini, N. Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats. Toxicology, 2008, 243(1-2), 207-215.
132. Maia Campos, P. M.; Gianeti, M. D.; Kanashiro, A.; Lucisano-Valim, Y. M.; Gaspar, L. R. In vitro antioxidant and in vivo photoprotective effects of an association of bioflavonoids with liposoluble vitamins. Photochem. Photobiol., 2006, 82(3), 683-688.
133. Zhao, J.; Jin, X.; Yaping, E.; Zheng, Z. S.; Zhang, Y. J.; Athar, M.; DeLeo, V. A.; Mukhtar, H.; Bickers, D. R.; Wang, Z. Y. Photoprotective effect of black tea extracts against UVB-induced phototoxicity in skin. Photochem. Photobiol., 1999, 70(4), 637-644.
134. Lee, S.; Kim, Y. J.; Kwon, S.; Lee, Y.; Choi, S. Y.; Park, J.; Kwon, H. J. Inhibitory effects of flavonoids on TNF-alpha-induced IL-8 gene expression in HEK 293 cells. BMB Rep., 2009, 42(5), 265-270.
135. Bureau, G.; Longpre, F.; Martinoli, M. G. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J. Neurosci. Res., 2008, 86(2), 403-410.
136. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediat. Inflamm., 2007, 2007, 45673.
137. Murakami, A.; Ashida, H.; Terao, J. Multitargeted cancer prevention by quercetin. Cancer Lett., 2008, 269(2), 315-325.
138. im, K.-S.; Rhee, K.-H.; Yoon, J.-H.; Lee, J. G.; Lee, J.-H.; Yoo, J.-B. Ginkgo biloba extract(EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral. Oncol., 2005, 41(4), 383-389.
139. Kang, J. W.; Kim, J. H.; Song, K.; Kim, S. H.; Yoon, J. H.; Kim, K. S. Kaempferol and quercetin, components of Ginkgo biloba extract(EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother. Res., 2009, 24 (Suppl 1), S77-S82.
140. Tan, J.; Wang, B.; Zhu, L. Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin. Chem. Biodivers., 2009, 6(7), 1101-1110.
141. Shan, B. E.; Wang, M. X.; Li, R. Q. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and surviving expression through Wnt/beta-catenin signaling pathway. Cancer Invest., 2009, 27(6), 604-612.
142. Warren, C. A.; Paulhill, K. J.; Davidson, L. A.; Lupton, J. R.; Taddeo, S. S.; Hong, M. Y.; Carroll, R. J.; Chapkin, R. S.; Turner, N. D. Quercetin May Suppress Rat Aberrant Crypt Foci Formation by Suppressing Inflammatory Mediators That Influence Proliferation and Apoptosis. J. Nutr., 2009, 139(1), 101-105.
143. Volate, S. R.; Davenport, D. M.; Muga, S. J.; Wargovich, M. J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements(quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis, 2005, 26(8), 1450-1456.
144. Kwon, K. H.; Murakami, A.; Tanaka, T.; Ohigashi, H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem. Pharmacol., 2005, 69(3), 395-406.
145. Du, G.; Lin, H.; Wang, M.; Zhang, S.; Wu, X.; Lu, L.; Ji, L.; Yu, L. Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells. Cancer Chemother. Pharmacol., 2009, 65(2), 277-287.
146. Morris, J. D. H.; Pramanik, R.; Zhang, X.; Carey, A.-M.; Ragavan, N.; Martin, F. L.; Muir, G. H. Selenium-or quercetin-induced retardation of DNA synthesis in primary prostate cells occurs in the presence of a oncomitant reduction in androgen-receptor activity. Cancer Lett., 2006, 239(1), 111-122
147. Lee, D.-H.; Szczepanski, M.; Lee, Y. J. Role of Bax in quercetin-induced poptosis in human prostate cancer cells. Biochem. Pharmacol., 2008, 5(12), 2345-2355.
148. Chow, J. M.; Shen, S. C.; Huan, S. K.; Lin, H. Y.; Chen, Y. C. Quercetin, but not rutin and quercitrin, prevention of H2O2-induced apoptosis via antioxidant activity and heme oxygenase 1 gene expression in macrophages. Biochem. Pharmacol., 2005, 69(12), 1839-1851.
149. Bournival, J.; Quessy, P.; Martinoli, M. G. Protective effects of resveratrol and quercetin against MPP+-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell. Mol. Neurobiol., 2009, 29(8), 1169-1180.
150. Hou, Y.; Aboukhatwa, M. A.; Lei, D. L.; Manaye, K.; Khan, I.; Luo, Y. Anti-depressant natural flavonols modulate BDNF and beta amyloid in neurons and hippocampus of double TgAD mice. Neuropharmacology, 2009, 58(6), 911-920.
151. Akaishi, T.; Morimoto, T.; Shibao, M.; Watanabe, S.; Sakai-Kato, K.; Utsunomiya-Tate, N.; Abe, K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett., 2008, 444(3), 280-285.
152. Ansari, M. A.; Abdul, H. M.; Joshi, G.; Opii, W. O.; Butterfield, D. A. Protective effect of quercetin in primary neurons against A[beta](1-42): elevance to Alzheimer's disease. J. Nutr. Biochem., 2009, 20(4), 269-275.
153. Mojzisova, G.; Sarissky, M.; Mirossay, L.; Martinka, P.; Mojzis, J. Effect of flavonoids on daunorubicin-induced toxicity in H9c2 Cardiomyoblasts. Phytother. Res., 2009, 23(1), 136-139.
154. Lodi, F.; Jimenez, R.; Moreno, L.; Kroon, P. A.; Needs, P. W.; Hughes, D. A.; Santos-Buelga, C.; Gonzalez-Paramas, A.; Cogolludo, A.; Lopez-Sepulveda, R.; Duarte, J.; Perez-Vizcaino, F. Glucuronidated and sulfated metabolites of the flavonoid quercetin prevent endothelial dysfunction but lack direct vasorelaxant effects in rat aorta. Atherosclerosis, 2009, 204(1), 34-39.
155. Kampkotter, A.; Timpel, C.; Zurawski, R. F.; Ruhl, S.; Chovolou, Y.; roksch, P.; Watjen, W. Increase of stress resistance and lifespan of Caenorhabditis elegans by quercetin. Comp. Biochem. Physiol. B. Biochem. Mol. Biol., 2008, 149(2), 314-323.
156. Sen, G.; Mukhopadhyay, S.; Ray, M.; Biswas, T. Quercetin interferes with iron metabolism in Leishmania donovani and targets ribonucleotide reductase to exert leishmanicidal activity. J. Antimicrob. Chemother., 2008, 61(5), 1066-1075.
157. Davis, J. M.; Murphy, E. A.; McClellan, J. L.; Carmichael, M. D.; Gangemi, J. D. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2008, 295(2), R505-R509.
158. Bischoff, S. C. Quercetin: potentials in the prevention and therapy of disease. Curr. Opin. Clin. Nutr. Metab. Care, 2008, 11(6), 733-740.
159. Hertog, M. G.; Sweetnam, P. M.; Fehily, A. M.; Elwood, P. C.; Kromhout, D. Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am. J. Clin. Nutr., 1997, 65(5), 1489-1494.
160. Bae, S.-C.; Jung, W.-J.; Lee, E.-J.; Yu, R.; Sung, M.-K. Effects of Antioxidant Supplements Intervention on the Level of Plasma Inflammatory Molecules and Disease Severity of Rheumatoid Arthritis Patients. J. Am. Coll. Nutr., 2009, 28(1), 56-62.
161. Kääriäinen, T. M.; Piltonen, M.; Ossola, B.; Kekki, H.; Lehtonen, S.; Nenonen, T.; Lecklin, A.; Raasmaja, A.; Männistö, P. T. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Res., 2008, 1203, 149-159.
162. Ossola, B.; Kääriäinen, T. M.; Raasmaja, A.; Männistö, P. T. Timedependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. Toxicology, 2008, 250(1), 1-8.
163. Ferry, D. R.; Smith, A.; Malkhandi, J.; Fyfe, D. W.; deTakats, P. G.; Anderson, D.; Baker, J.; Kerr, D. J. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res., 1996, 2(4), 659-668.
164. Chow, H. H.; Cai, Y.; Alberts, D. S.; Hakim, I.; Dorr, R.; Shahi, F.; Crowell, J. A.; Yang, C. S.; Hara, Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev., 2001, 10(1), 53-58.
165. Lee, M. J.; Maliakal, P.; Chen, L.; Meng, X.; Bondoc, F. Y.; Prabhu, S.; Lambert, G.; Mohr, S.; Yang, C. S. Pharmacokinetics of tea catechins after ingestion of green tea and(-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomarkers Prev., 2002, 11(10 Pt 1), 1025-1032.
166. Donovan, J. L.; Crespy, V.; Oliveira, M.; Cooper, K. A.; Gibson, B. B.; Williamson, G. (+)-Catechin is more bioavailable than (-)-catechin: relevance to the bioavailability of catechin from cocoa. Free Radic. Res., 2006, 40(10), 1029-1034.
167. Nakagawa, K.; Okuda, S.; Miyazawa, T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem., 1997, 61(12), 1981-1985.
168. Holt, R. R.; Lazarus, S. A.; Sullards, M. C.; Zhu, Q. Y.; Schramm, D. D.; ammerstone, J. F.; Fraga, C. G.; Schmitz, H. H.; Keen, C. L. Procyanidin dimer B2 [epicatechin-(4 beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr., 2002, 76(4), 798-804.
169. Spencer, J. P. E.; Schroeter, H.; Shenoy, B.; S. Srai, S. K.; Debnam, E. S.; Rice-Evans, C. Epicatechin Is the Primary Bioavailable Form of the Procyanidin Dimers B2 and B5 after Transfer across the Small Intestine. Biochem. Biophys. Res. Commun., 2001, 285(3), 588-593.
170. Donovan, J. L.; Bell, J. R.; Kasim-Karakas, S.; German, J. B.; Walzem, R. L.; Hansen, R. J.; Waterhouse, A. L. In Catechin is present as metabolites in human plasma after consumption of red wine, Amer Inst Nutrition: 1999; pp. 1662-1668.
171. Van Amelsvoort, J. M.; Van Hof, K. H.; Mathot, J. N.; Mulder, T. P.; Wiersma, A.; Tijburg, L. B. Plasma concentrations of individual tea catechins after a single oral dose in humans. Xenobiotica, 2001, 31(12), 891-901.
172. Donovan, J. L.; Kasim-Karakas, S.; German, J. B.; Waterhouse, A. L. Urinary excretion of catechin metabolites by human subjects after red wine consumption. Br. J. Nutr., 2002, 87(01), 31-37.
173. Natsume, M.; Osakabe, N.; Oyama, M.; Sasaki, M.; Baba, S.; Nakamura, Y.; Osawa, T.; Terao, J. Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic. Biol. Med., 2003, 34(7), 840-849.
174. Lu, H.; Meng, X. F.; Yang, C. S. Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate. Drug Metab. Dispos., 2003, 31(5), 572-579.
175. Rios, L. Y.; Gonthier, M. P.; Remesy, C.; Mila, I.; Lapierre, C.; Lazarus, S. A.; Williamson, G.; Scalbert, A. Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr., 2003, 77(4), 912-918.
176. Ferruzzi, M. G.; Lobo, J. K.; Janle, E. M.; Cooper, B.; Simon, J. E.; Wu, Q. L.; Welch, C.; Ho, L.; Weaver, C.; Pasinetti, G. M. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J. Alzheimers Dis., 2009, 18(1), 113-124.
177. Serafini, M.; Bugianesi, R.; Maiani, G.; Valtuena, S.; De Santis, S.; Crozier, A. Plasma antioxidants from chocolate. Nature, 2003, 424(6952), 1013.
178. Roura, E.; Andres-Lacueva, C.; Estruch, R.; Mata-Bilbao, M. L.; Izquierdo-Pulido, M.; Waterhouse, A. L.; Lamuela-Raventos, R. M. Milk does not affect the bioavailability of cocoa powder flavonoid in healthy human. Ann. Nutr. Metab., 2007, 51(6), 493-498.
179. Mullen, W.; Borges, G.; Donovan, J. L.; Edwards, C. A.; Serafini, M.; Lean, M. E.; Crozier, A. Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans. Am. J. Clin. Nutr., 2009, 89(6), 1784-1791.
180. Xu, Y.; Zhang, J. J.; Xiong, L.; Zhang, L.; Sun, D.; Liu, H. Green tea polyphenols inhibit cognitive impairment induced by chronic cerebral hypoperfusion via modulating oxidative stress. J. Nutr. Biochem., 2009, 21(8), 741-748.
181. Yokozawa, T.; Nakagawa, T.; Kitani, K. Antioxidative Activity of Green Tea Polyphenol in Cholesterol-Fed Rats. J. Agric. Food Chem., 2002, 50(12), 3549-3552.
182. Kimura, M.; Umegaki, K.; Kasuya, Y.; Sugisawa, A.; Higuchi, M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur. J. Clin. Nutr., 2002, 56(12), 1186-1193.
183. Rozan, P.; Hidalgo, S.; Nejdi, A.; Bisson, J. F.; Lalonde, R.; Messaoudi, M. Preventive antioxidant effects of cocoa polyphenolic extract on free radical production and cognitive performances after heat exposure in Wistar rats. J. Food Sci., 2007, 72(3), S203-S206.
184. Wang, J. F.; Schramm, D. D.; Holt, R. R.; Ensunsa, J. L.; Fraga, C. G.; Schmitz, H. H.; Keen, C. L. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J. Nutr., 2000, 130(8S Suppl), 2115S-2119S.
185. Pearson, D. A.; Schmitz, H. H.; Lazarus, S. A.; Keen, C. L.; Lester, P. Inhibition of in Vitro low-density lipoprotein oxidation by oligomeric procyanidins present in chocolate and cocoas. In Methods in Enzymology, Academic Press: 2001; Vol. 335, pp. 350-360.
186. Keen, C. L.; Holt, R. R.; Oteiza, P. I.; Fraga, C. G.; Schmitz, H. H. Cocoa antioxidants and cardiovascular health. Am. J. Clin. Nutr., 2005, 81(1 Suppl), 298S-303S.
187. Mehrinfar, R.; Frishman, W. H. Flavanol-rich cocoa: a cardioprotective nutraceutical. Cardiol. Rev., 2008, 16(3), 109-115.
188. Hamed, M. S.; Gambert, S.; Bliden, K. P.; Bailon, O.; Singla, A.; Antonino, M. J.; Hamed, F.; Tantry, U. S.; Gurbel, P. A. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med. J., 2008, 101(12), 1203-1208.
189. Tinahones, F. J.; Rubio, M. A.; Garrido-Sanchez, L.; Ruiz, C.; Gordillo, E.; Cabrerizo, L.; Cardona, F. Green Tea Reduces LDL Oxidability and Improves Vascular Function. J. Am. Coll. Nutr., 2008, 27(2), 209-213.
190. Murphy, K. J.; Chronopoulos, A. K.; Singh, I.; Francis, M. A.; Moriarty, H.; Pike, M. J.; Turner, A. H.; Mann, N. J.; Sinclair, A. J. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am. J. Clin. Nutr., 2003, 77(6), 1466-1473.
191. Yamakuchi, M.; Bao, C.; Ferlito, M.; Lowenstein, C. J. Epigallocatechin gallate inhibits endothelial exocytosis. Biol. Chem., 2008, 389(7), 935-941.
192. Kavanagh, K. T.; Hafer, L. J.; Kim, D. W.; Mann, K. K.; Sherr, D. H.; Rogers, A. E.; Sonenshein, G. E. Green tea extracts decrease carcinogen induced mammary tumor burden in rats and rate of breast cancer cell proliferation in culture. J. Cell. Biochem., 2001, 82(3), 387-398.
193. Kushima, Y.; Iida, K.; Nagaoka, Y.; Kawaratani, Y.; Shirahama, T.; Sakaguchi, M.; Baba, K.; Hara, Y.; Uesato, S. Inhibitory effect of (-)-epigallocatechin and (-)-epigallocatechin gallate against heregulin beta1-induced migration/invasion of the MCF-7 breast carcinoma cell line. Biol. Pharm. Bull., 2009, 32(5), 899-904.
194. Siddiqui, I. A.; Raisuddin, S.; Shukla, Y. Protective effects of black tea extract on testosterone induced oxidative damage in prostate. Cancer Lett., 2005, 227(2), 125-132.
195. Jourdain, C.; Tenca, G.; Deguercy, A.; Troplin, P.; Poelman, D. In-vitro effects of polyphenols from cocoa and beta-sitosterol on the growth of human prostate cancer and normal cells. Eur. J. Cancer Prev., 2006, 15(4), 353-361.
196. Lee, A. H.; Fraser, M. L.; Binns, C. W. Tea, coffee and prostate cancer. Mol. Nutr. Food Res., 2009, 53(2), 256-265.
197. Ran, Z. H.; Xu, Q.; Tong, J. L.; Xiao, S. D. Apoptotic effect of Epigallocatechin-3-gallate on the human gastric cancer cell line MKN45 via activation of the mitochondrial pathway. World J. Gastroenterol., 2007, 13(31), 4255-4259.
198. Suzuki, E.; Yorifuji, T.; Takao, S.; Komatsu, H.; Sugiyama, M.; Ohta, T.; Ishikawa-Takata, K.; Doi, H. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann. Epidemiol., 2009, 19(10), 732-739.
199. Adachi, S.; Shimizu, M.; Shirakami, Y.; Yamauchi, J.; Natsume, H.; Matsushima-Nishiwaki, R.; To, S.; Weinstein, I. B.; Moriwaki, H.; Kozawa, O. (-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. Carcinogenesis, 2009, 30(9), 1544-1552.
200. Milligan, S. A.; Burke, P.; Coleman, D. T.; Bigelow, R. L.; Steffan, J. J.; Carroll, J. L.; Williams, B. J.; Cardelli, J. A. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin. Cancer Res., 2009, 15(15), 4885-4894.
201. Li, Y.; Zhang, T.; Jiang, Y.; Lee, H.-F.; Schwartz, S. J.; Sun, D. (-)-Epigallocatechin-3-gallate Inhibits Hsp90 Function by Impairing Hsp90 Association with Cochaperones in Pancreatic Cancer Cell Line Mia Paca-2. Mol. Pharm., 2009, 6(4), 1152-1159.
202. Yasuda, Y.; Shimizu, M.; Sakai, H.; Iwasa, J.; Kubota, M.; Adachi, S.; Osawa, Y.; Tsurumi, H.; Hara, Y.; Moriwaki, H. (-)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R. Chem. Biol. Interact., 2009, 182(2-3), 159-164.
203. Kaufmann, R.; Henklein, P.; Settmacher, U. Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncol. Rep., 2009, 21(5), 1261-1267.
204. Saul, N.; Pietsch, K.; Menzel, R.; Stürzenbaum, S. R.; Steinberg, C. E. W. Catechin induced longevity in C. elegans: From key regulator genes to disposable soma. Mech. Ageing Dev., 2009, 130(8), 477-486.
205. Abbas, S.; Wink, M. Epigallocatechin gallate from green tea (Camellia sinensis) increases lifespan and stress resistance in Caenorhabditis elegans. Planta Med., 2009, 75(3), 216-221.
206. Jeon, H. Y.; Kim, J. K.; Kim, W. G.; Lee, S. J. Effects of oral epigallocatechin gallate supplementation on the minimal erythema dose and UV-induced skin damage. Skin Pharmacol. Physiol., 2009, 22(3), 137-141.
207. Kim, C. Y.; Lee, C.; Park, G. H.; Jang, J. H. Neuroprotective effect of epigallocatechin-3-gallate against beta-amyloid-induced oxidative and nitrosative cell death via augmentation of antioxidant defense capacity. Arch. Pharm. Res., 2009, 32(6), 869-881.
208. Lee, Y. K.; Yuk, D. Y.; Lee, J. W.; Lee, S. Y.; Ha, T. Y.; Oh, K. W.; Yun, Y. P.; Hong, J. T. (-)-Epigallocatechin-3-gallate prevents lipopolysaccharideinduced elevation of beta-amyloid generation and memory deficiency. Brain Res., 2009, 1250, 164-174.
209. Wang, H.; Wen, Y.; Du, Y.; Yan, X.; Guo, H.; Rycroft, J. A.; Boon, N.; Kovacs, E. M.; Mela, D. J. Effects of catechin enriched green tea on body composition. Obesity (Silver Spring), 2009, 18(4), 773-779.
210. Lee, M. S.; Kim, C. T.; Kim, Y. Green tea (-)-epigallocatechin-3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann. Nutr. Metab., 2009, 54(2), 151-157.
211. Grassi, D.; Desideri, G.; Necozione, S.; Lippi, C.; Casale, R.; Properzi, G.; Blumberg, J. B.; Ferri, C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J. Nutr., 2008, 138(9), 1671-1676.
212. Tsuneki, H.; Ishizuka, M.; Terasawa, M.; Wu, J. B.; Sasaoka, T.; Kimura, I. Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol., 2004, 4, 18.
213. Ried, K.; Frank, O. R.; Stocks, N. P. Dark chocolate or tomato extract for prehypertension: a randomised controlled trial. BMC Complement. Altern. Med., 2009, 9, 22.
214. Datla, K. P.; Zbarsky, V.; Rai, D.; Parkar, S.; Osakabe, N.; Aruoma, O. I.; Dexter, D. T. Short-Term Supplementation with Plant Extracts Rich in Flavonoids Protect Nigrostriatal Dopaminergic Neurons in a Rat Model of Parkinson's Disease. J. Am. Coll. Nutr., 2007, 26(4), 341-349.
215. Kikuchi, N.; Ohmori, K.; Shimazu, T.; Nakaya, N.; Kuriyama, S.; Nishino, Y.; Tsubono, Y.; Tsuji, I. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Br. J. Cancer, 2006, 95(3), 371-373.
216. Bonkovsky, H. L. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann. Intern. Med., 2006, 144(1), 68-71.
217. Stevens, T.; Qadri, A.; Zein, N. N. Two Patients with Acute Liver Injury Associated with Use of the Herbal Weight-Loss Supplement Hydroxycut. Ann. Int. Med., 2005, 142(6), 477-478.
218. McCann, D.; Barrett, A.; Cooper, A.; Crumpler, D.; Dalen, L.; Grimshaw, K.; Kitchin, E.; Lok, K.; Porteous, L.; Prince, E.; Sonuga-Barke, E.; Warner, J. O.; Stevenson, J. Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. Lancet, 2007, 370(9598), 1560-1567.
219. Galvano, F.; La Fauci, L.; Vitaglione, P.; Fogliano, V.; Vanella, L.; Felgines, C. Bioavailability, antioxidant and biological properties of the natural freeradical scavengers cyanidin and related glycosides. Ann. Ist. Super. Sanita, 2007, 43(4), 382-393.
220. Kay, C. D.; Mazza, G.; Holub, B. J. Anthocyanins Exist in the Circulation Primarily as Metabolites in Adult Men. J. Nutr., 2005, 135(11), 2582-2588.
221. Mertens-Talcott, S. U.; Rios, J.; Jilma-Stohlawetz, P.; Pacheco-Palencia, L. A.; Meibohm, B.; Talcott, S. T.; Derendorf, H. Pharmacokinetics of Anthocyanins and Antioxidant Effects after the Consumption of Anthocyanin-Rich Açai Juice and Pulp (Euterpe oleracea Mart.) in Human Healthy Volunteers. J. Agric. Food Chem., 2008, 56(17), 7796-7802.
222. Milbury, P. E.; Cao, G.; Prior, R. L.; Blumberg, J. Bioavailablility of elderberry anthocyanins. Mech. Ageing Dev., 2002, 123(8), 997-1006.
223. Galvano, F.; La Fauci, L.; Lazzarino, G.; Fogliano, V.; Ritieni, A.; Ciappellano, S.; Battistini, N. C.; Tavazzi, B.; Galvano, G. Cyanidins: metabolism and biological properties. J. Nutr. Biochem., 2004, 15(1), 2-11.
224. Garcia-Alonso, M.; Minihane, A.-M.; Rimbach, G.; Rivas-Gonzalo, J. C.; de Pascual-Teresa, S. Red wine anthocyanins are rapidly absorbed in humans and affect monocyte chemoattractant protein 1 levels and antioxidant capacity of plasma. J. Nutr. Biochem., 2009, 20(7), 521-529.
225. Miyazawa, T.; Nakagawa, K.; Kudo, M.; Muraishi, K.; Someya, K. Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans. J. Agric. Food Chem., 1999, 47(3), 1083-1091.
226. Lehtonen, H.-M.; Rantala, M.; Suomela, J.-P.; Viitanen, M.; Kallio, H. Urinary Excretion of the Main Anthocyanin in Lingonberry (Vaccinium vitis-idaea), Cyanidin 3-O-Galactoside, and Its Metabolites. J. Agric. Food Chem., 2009, 57(10), 4447-4451.
227. Frank, T.; Sonntag, S.; Strass, G.; Bitsch, I.; Bitsch, R.; Netzel, M. Urinary pharmacokinetics of cyanidin glycosides in healthy young men following consumption of elderberry juice. Int. J. Clin. Pharmacol. Res., 2005, 25(2), 47-56.
228. Matsumoto, H.; Inaba, H.; Kishi, M.; Tominaga, S.; Hirayama, M.; Tsuda, T. Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J. Agric. Food Chem., 2001, 49(3), 1546-1551.
229. Tian, Q. G.; Giusti, M. M.; Stoner, G. D.; Schwartz, S. J. Urinary excretion of black raspberry (Rubus occidentalis) anthocyanins and their metabolites. J. Agric. Food Chem., 2006, 54(4), 1467-1472.
230. Hassimotto, N. M. A.; Genovese, M. I.; Lajolo, F. M. Absorption and metabolism of cyanidin-3-glucoside and cyanidin-3-rutinoside extracted from wild mulberry (Morus nigra L.) in rats. Nutr. Res., 2008, 28(3), 198-207.
231. Charron, C. S.; Clevidence, B. A.; Britz, S. J.; Novotny, J. A. Effect of Dose Size on Bioavailability of Acylated and Nonacylated Anthocyanins from Red Cabbage (Brassica oleracea L. Var. capitata). J. Agric. Food Chem., 2007, 55(13), 5354-5362.
232. Hollands, W.; Brett, G. M.; Dainty, J. R.; Teucher, B.; Kroon, P. A. Urinary excretion of strawberry anthocyanins is dose dependent for physiological oral doses of fresh fruit. Mol. Nutr. Food Res., 2008, 52(10), 1097-1105.
233. Wu, X.; Pittman, H. E. III; Prior, R. L. Pelargonidin Is Absorbed and Metabolized Differently than Cyanidin after Marionberry Consumption in Pigs. J. Nutr., 2004, 134(10), 2603-2610.
234. Charron, C. S.; Kurilich, A. C.; Clevidence, B. A.; Simon, P. W.; Harrison, D. J.; Britz, S. J.; Baer, D. J.; Novotny, J. A. Bioavailability of Anthocyanins from Purple Carrot Juice: Effects of Acylation and Plant Matrix. J. Agric. Food Chem., 2009, 57(4), 1226-1230.
235. Felgines, C.; Talavera, S.; Gonthier, M. P.; Texier, O.; Scalbert, A.; Lamaison, J. L.; Remesy, C. Strawberry anthocyanins are recovered in urine as glucuro-and sulfoconjugates in humans. J. Nutr., 2003, 133(5), 1296-1301.
236. Felgines, C.; Talavera, S.; Texier, O.; Gil-Izquierdo, A.; Lamaison, J. L.; Remesy, C. Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans. J. Agric. Food Chem., 2005, 53(20), 7721-7727.
237. Woodward, G.; Kroon, P.; Cassidy, A.; Kay, C. Anthocyanin Stability and Recovery: Implications for the Analysis of Clinical and Experimental Samples. J. Agric. Food Chem., 2009, 57(12), 5271-5278.
238. Vitaglione, P.; Donnarumma, G.; Napolitano, A.; Galvano, F.; Gallo, A.; Scalfi, L.; Fogliano, V. Protocatechuic Acid Is the Major Human Metabolite of Cyanidin-Glucosides. J. Nutr., 2007, 137(9), 2043-2048.
239. Kurilich, A. C.; Clevidence, B. A.; Britz, S. J.; Simon, P. W.; Novotny, J. A. Plasma and Urine Responses Are Lower for Acylated vs Nonacylated Anthocyanins from Raw and Cooked Purple Carrots. J. Agric. Food Chem., 2005, 53(16), 6537-6542.
240. Fukumoto, L. R.; Mazza, G. Assessing Antioxidant and Prooxidant Activities of Phenolic Compounds. J. Agric. Food Chem., 2000, 48(8), 3597-3604.
241. Bao, L.; Yao, X.-S.; Yau, C.-C.; Tsi, D.; Chia, C.-S.; Nagai, H.; Kurihara, H. Protective Effects of Bilberry (Vaccinium myrtillus L.) Extract on Restraint Stress-Induced Liver Damage in Mice. J. Agric. Food Chem., 2008, 56(17), 7803-7807.
242. Metzger, B. T.; Barnes, D. M.; Reed, J. D. Purple Carrot (Daucus carota L.) Polyacetylenes Decrease Lipopolysaccharide-Induced Expression of Inflammatory Proteins in Macrophage and Endothelial Cells. J. Agric. Food Chem., 2008, 56(10), 3554-3560.
243. Lyall, K. A.; Hurst, S. M.; Cooney, J.; Jensen, D.; Lo, K.; Hurst, R. D.; Stevenson, L. M. Short-term blackcurrant extract consumption modulates exercise-induced oxidative stress and lipopolysaccharide-stimulated inflammatory responses. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2009, 297(1), R70-R81.
244. Palikova, I.; Valentova, K.; Oborna, I.; Ulrichova, J. Protectivity of blue honeysuckle extract against oxidative human endothelial cells and rat hepatocyte damage. J. Agric. Food Chem., 2009, 57(15), 6584-6589.
245. Goupy, P.; Bautista-Ortin, A. B.; Fulcrand, H.; Dangles, O. Antioxidant activity of wine pigments derived from anthocyanins: hydrogen transfer reactions to the dpph radical and inhibition of the heme-induced peroxidation of linoleic acid. J. Agric. Food Chem., 2009, 57(13), 5762-5770.
246. Chen, G.; Bower, K. A.; Xu, M.; Ding, M.; Shi, X.; Ke, Z. J.; Luo, J. Cyanidin-3-glucoside reverses ethanol-induced inhibition of neurite outgrowth: role of glycogen synthase kinase 3 Beta. Neurotox. Res., 2009, 15(4), 321-331.
247. Hafeez, B. B.; Siddiqui, I. A.; Asim, M.; Malik, A.; Afaq, F.; Adhami, V. M.; Saleem, M.; Din, M.; Mukhtar, H. A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res., 2008, 68(20), 8564-8572.
248. Wang, L.-S.; Hecht, S. S.; Carmella, S. G.; Yu, N.; Larue, B.; Henry, C.; McIntyre, C.; Rocha, C.; Lechner, J. F.; Stoner, G. D. Anthocyanins in Black Raspberries Prevent Esophageal Tumors in Rats. Cancer Prev. Res., 2009, 2(1), 84-93.
249. Cooke, D.; Schwarz, M.; Boocock, D.; Winterhalter, P.; Steward, W. P.; Gescher, A. J.; Marczylo, T. H. Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis--relationship with tissue anthocyanin levels. Int. J. Cancer, 2006, 119(9), 2213-2220.
250. Thomasset, S.; Berry, D. P.; Cai, H.; West, K.; Marczylo, T. H.; Marsden, D.; Brown, K.; Dennison, A.; Garcea, G.; Miller, A.; Hemingway, D.; Steward, W. P.; Gescher, A. J. Pilot Study of Oral Anthocyanins for Colorectal Cancer Chemoprevention. Cancer Prev. Res., 2009, 2(7), 625-633.
251. Zapolska-Downar, D.; Nowicka, G.; Sygitowicz, G.; Jarosz, M. Anthocyanin-Rich Aronox Extract from Aronia melanocarpa E Protects against 7b-Hydroxycholesterol-Induced Apoptosis of Endothelial Cells. Ann.Nutr. Metab., 2008, 53(3-4), 283-294.
252. Xia, M.; Ling, W.; Zhu, H.; Ma, J.; Wang, Q.; Hou, M.; Tang, Z.; Guo, H.; Liu, C.; Ye, Q. Anthocyanin attenuates CD40-mediated endothelial cell activation and apoptosis by inhibiting CD40-induced MAPK activation. Atherosclerosis, 2009, 202(1), 41-47.
253. Toufektsian, M. C.; de Lorgeril, M.; Nagy, N.; Salen, P.; Donati, M. B.; Giordano, L.; Mock, H. P.; Peterek, S.; Matros, A.; Petroni, K.; Pilu, R.; Rotilio, D.; Tonelli, C.; de Leiris, J.; Boucher, F.; Martin, C. Chronic dietary intake of plant-derived anthocyanins protects the rat heart against ischemiareperfusion injury. J. Nutr., 2008, 138(4), 747-752.
254. Xia, X.; Ling, W.; Ma, J.; Xia, M.; Hou, M.; Wang, Q.; Zhu, H.; Tang, Z. An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice. J. Nutr., 2006, 136(8), 2220-2225.
255. Qin, Y.; Xia, M.; Ma, J.; Hao, Y.; Liu, J.; Mou, H.; Cao, L.; Ling, W. Anthocyanin supplementation improves serum LDL-and HDL-cholesterol concentrations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am. J. Clin. Nutr., 2009, 90(3), 485-492.
256. Butelli, E.; Titta, L.; Giorgio, M.; Mock, H. P.; Matros, A.; Peterek, S.; Schijlen, E.; Hall, R. D.; Bovy, A. G.; Luo, J.; Martin, C. Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nat. Biotechnol., 2008, 26(11), 1301-1308.
257. DeFuria, J.; Bennett, G.; Strissel, K. J.; Perfield, J. W. 2nd; Milbury, P. E.; Greenberg, A. S.; Obin, M. S. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J. Nutr., 2009, 139(8), 1510-1516.
258. Matsumoto, H.; Nakamura, Y.; Tachibanaki, S.; Kawamura, S.; Hirayama, M. Stimulatory Effect of Cyanidin 3-Glycosides on the Regeneration of Rhodopsin. J. Agric. Food Chem., 2003, 51(12), 3560-3563.
259. Lee, J.; Lee, H. K.; Kim, C. Y.; Hong, Y. J.; Choe, C. M.; You, T. W.; Seong, G. J. Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br. J. Nutr., 2005, 93(06), 895-899.
260. Seymour, E. M.; Singer, A. A.; Kirakosyan, A.; Urcuyo-Llanes, D. E.; Kaufman, P. B.; Bolling, S. F. Altered hyperlipidemia, hepatic steatosis, and hepatic peroxisome proliferator-activated receptors in rats with intake of tart cherry. J. Med. Food, 2008, 11(2), 252-259.
261. Chen, G.; Luo, J. Anthocyanins: are they beneficial in treating ethanol neurotoxicity? Neurotox. Res., 2009, 17(1), 91-101.
262. Li, C.-Y.; Xu, H.-D.; Zhao, B.-T.; Chang, H.-I.; Rhee, H.-I. Gastroprotective effect of cyanidin 3-glucoside on ethanol-induced gastric lesions in rats. Alcohol., 2008, 42(8), 683-687.
263. Galvano, F.; Frigiola, A.; Gazzolo, D.; Biondi, A.; Malaguarnera, M.; Li Volti, G. Endothelial protective effects of anthocyanins: the underestimated role of their metabolites. Ann. Nutr. Metab., 2009, 54(2), 158-159.
264. Møller, P.; Loft, S.; Alfthan, G.; Freese, R. Oxidative DNA damage in circulating mononuclear blood cells after ingestion of blackcurrant juice or anthocyanin-rich drink. Mut. Res./Fundam. Mol. Mech. Mutagenesis, 2004, 551(1-2), 119-126.
265. Wenzel, E.; Somoza, V. Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res., 2005, 49(5), 472-481.
266. Day, A. J.; DuPont, M. S.; Ridley, S.; Rhodes, M.; Rhodes, M. J. C.; Morgan, M. R. A.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver [beta]-glucosidase activity. FEBS Lett., 1998, 436(1), 71-75.
267. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E. Jr.; Walle, U. K. High absorption but very low bioavailibity of oral resveratrol in humans. Drug Metab. Dispos., 2004, 32(12), 1377-1382.
268. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; van Breemen, R. B. Human, Rat, and Mouse Metabolism of Resveratrol. Pharm. Res., 2002, 19(12), 1907-1914.
269. Soleas, G. J.; Angelini, M.; Grass, L.; Diamandis, E. P.; Goldberg, D. M.; Lester, P. Absorption of trans-resveratrol in rats. In Methods in Enzymology, Academic Press: 2001; Vol. 335, pp. 145-154.
270. Udenigwe, C. C.; Ramprasath, V. R.; Aluko, R. E.; Jones, P. J. H. Potential of resveratrol in anticancer and anti-inflammatory therapy. Nutr. Rev., 2008, 66(8), 445.
271. Howitz, K. T.; Bitterman, K. J.; Cohen, H. Y.; Lamming, D. W.; Lavu, S.; Wood, J. G.; Zipkin, R. E.; Chung, P.; Kisielewski, A.; Zhang, L.-L.; Scherer, B.; Sinclair, D. A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954), 191-196.
272. Baur, J. A.; Sinclair, D. A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov., 2006, 5(6), 493-506.
273. Signorelli, P.; Ghidoni, R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem., 2005, 16(8), 449-466.
274. Baur, J. A. Obesity: Do Grapes Hold the Answer? [Miscellaneous]. Pediatr. Res., 2007, 61(6), 633.
275. Kaeberlein, M.; Rabinovitch, P. S. MEDICINE: Grapes versus gluttony. Nature, 2006, 444(7117), 280-281.
276. Viswanathan, M.; Kim, S. K.; Berdichevsky, A.; Guarente, L. A Role for SIR-2.1 Regulation of ER Stress Response Genes in Determining C. elegans Life Span. Dev. Cell, 2005, 9(5), 605-615.
277. Wood, J. G.; Rogina, B.; Lavu, S.; Howitz, K.; Helfand, S. L.; Tatar, M.; Sinclair, D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 2004, 430(7000), 686-689.
278. Valenzano, D. R.; Terzibasi, E.; Genade, T.; Cattaneo, A.; Domenici, L.; Cellerino, A. Resveratrol Prolongs Lifespan and Retards the Onset of Age-Related Markers in a Short-Lived Vertebrate. Curr. Biol., 2006, 16(3), 296-300.
279. Pearson, K. J.; Baur, J. A.; Lewis, K. N.; Peshkin, L.; Price, N. L.; Labinskyy, N.; Swindell, W. R.; Kamara, D.; Minor, R. K.; Perez, E.; Jamieson, H. A.; Zhang, Y.; Dunn, S. R.; Sharma, K.; Pleshko, N.; Woollett, L. A.; Csiszar, A.; Ikeno, Y.; Le Couteur, D.; Elliott, P. J.; Becker, K. G.; Navas, P.; Ingram, D. K.; Wolf, N. S.; Ungvari, Z.; Sinclair, D. A.; de Cabo, R. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab., 2008, 8(2), 157-168.
280. Reagan-Shaw, S.; Nihal, M.; Ahmad, N. Dose translation from animal to human studies revisited. FASEB J., 2008, 22(3), 659-661.
281. Williams, L. D.; Burdock, G. A.; Edwards, J. A.; Beck, M.; Bausch, J. Safety studies conducted on high-purity trans-resveratrol in experimental animals. Food Chem. Toxicol., 2009, 47(9), 2170-2182.
282. Boocock, D. J.; Faust, G. E. S.; Patel, K. R.; Schinas, A. M.; Brown, V. A.; Ducharme, M. P.; Booth, T. D.; Crowell, J. A.; Perloff, M.; Gescher, A. J.; Steward, W. P.; Brenner, D. E. Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent. Cancer Epidemiol. Biomarkers Prev., 2007, 16(6), 1246-1252.
283. Aribal-Kocatürk, P.; Özelçi Kavas, G.; Iren Büyükkag̈nici, D. Pretreatment Effect of Resveratrol on Streptozotocin-Induced Diabetes in Rats. Biol. Trace. Element. Res., 2007, 118(3), 244-249.
284. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; Geny, B.; Laakso, M.; Puigserver, P.; Auwerx, J. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1[alpha]. Cell, 2006, 127(6), 1109-1122.
285. Yousuf, S.; Atif, F.; Ahmad, M.; Hoda, N.; Ishrat, T.; Khan, B.; Islam, F. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res., 2009, 1250, 242-253.
286. Karuppagounder, S. S.; Pinto, J. T.; Xu, H.; Chen, H. L.; Beal, M. F.; Gibson, G. E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int., 2009, 54(2), 111-118.
287. Harper, C. E.; Patel, B. B.; Wang, J.; Arabshahi, A.; Eltoum, I. A.; Lamartiniere, C. A. Resveratrol suppresses prostate cancer progression in transgenic mice. Carcinogenesis, 2007, 28(9), 1946-1953.
288. Busquets, S.; Ametller, E.; Fuster, G.; Olivan, M.; Raab, V.; Argilés, J. M.; López-Soriano, F. J. Resveratrol, a natural diphenol, reduces metastatic growth in an experimental cancer model. Cancer Lett., 2007, 245(1-2), 144-148.
289. Trincheri, N. F.; Nicotra, G.; Follo, C.; Castino, R.; Isidoro, C. Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis, 2007, 28(5), 922-931.
290. Van Ginkel, P. R.; Sareen, D.; Subramanian, L.; Walker, Q.; Darjatmoko, S. R.; Lindstrom, M. J.; Kulkarni, A.; Albert, D. M.; Polans, A. S. Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin. Cancer Res., 2007, 13(17), 5162-5169.
291. Zhou, R.; Fukui, M.; Choi, H. J.; Zhu, B. T. Induction of a reversible, noncytotoxic S-phase delay by resveratrol: implications for a mechanism of lifespan prolongation and cancer protection. Br. J. Pharmacol., 2009, 158(2), 462-474.
292. Yang, D. L.; Zhang, H. G.; Xu, Y. L.; Gao, Y. H.; Yang, X. J.; Hao, X. Q.; Li, X. H. Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats. Clin. Exp. Pharmacol. Physiol., 2009, 37(2), 150-155.
293. Brookins Danz, E. D.; Skramsted, J.; Henry, N.; Bennett, J. A.; Keller, R. S. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Rad. Biol. Med., 2009, 46(12), 1589-1597.
294. Jung, C. M.; Heinze, T. M.; Schnackenberg, L. K.; Mullis, L. B.; Elkins, S. A.; Elkins, C. A.; Steele, R. S.; Sutherland, J. B. Interaction of dietary resveratrol with animal-associated bacteria. FEMS Microb. Lett., 2009, 297(2), 266-273.
295. Berardi, V.; Ricci, F.; Castelli, M.; Galati, G.; Risuleo, G. Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use. J. Exp. Clin. Cancer Res., 2009, 28, 96.
296. Lee, M.; Kim, S.; Kwon, O.-K.; Oh, S.-R.; Lee, H.-K.; Ahn, K. Antiinflammatory and anti-asthmatic effects of resveratrol, a polyphenolic stilbene, in a mouse model of allergic asthma. Int. Immunopharmacol., 2009, 9(4), 418-424.
297. Kuroiwa, Y.; Nishikawa, A.; Kitamura, Y.; Kanki, K.; Ishii, Y.; Umemura, T.; Hirose, M. Protective effects of benzyl isothiocyanate and sulforaphane but not resveratrol against initiation of pancreatic carcinogenesis in hamsters. Cancer Lett., 2006, 241(2), 275-280.
298. Wenzel, E.; Soldo, T.; Erbersdobler, H.; Somoza, V. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res., 2005, 49(5), 482-494.
299. Simons, A. L.; Renouf, M.; Hendrich, S.; Murphy, P. A. Human gut microbial degradation of flavonoids: structure-function relationships. J. Agric. Food Chem., 2005, 53(10), 4258-4263.